RBC Capital Reiterates Outperform on QuidelOrtho, Maintains $61 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho (NASDAQ:QDEL) and maintained a $61 price target.
August 16, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on QuidelOrtho and maintained a $61 price target.
The reiteration of an Outperform rating and the maintenance of a $61 price target by RBC Capital is a positive signal for investors, suggesting confidence in QuidelOrtho's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100